1. |
Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol, 1949, 25(4): 647-655.
|
2. |
Park HS, Bae JS, Jang KY, et al. Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology. J Korean Med Sci, 2011, 26(8): 1023-1030.
|
3. |
Cai X, Zhai J, Kaplan DE, et al. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology, 2012, 56(5): 1804-1816.
|
4. |
Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer, 1985, 55(1): 124-135.
|
5. |
Libbrecht L. Hepatic progenitor cells in human liver tumor development. World J Gastroenterol, 2006, 12(39): 6261-6265.
|
6. |
Bosman FT, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer, 2010: 225-227.
|
7. |
Garancini M, Goffredo P, Pagni F, et al. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl, 2014, 20(8): 952-959.
|
8. |
Green FL, Balch CM, Fleming ID, et al. AJCC Cancer Staging Manual: TNM classification of Malignant Tumors (6th ed.). New York: Springer, 2002: 131-138.
|
9. |
Wang J, Wang F, Kessinger A. Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol, 2010, 2010. pii: 917356.
|
10. |
Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer, 2002, 94(7): 2040-2046.
|
11. |
Akiba J, Nakashima O, Hattori S, et al. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol, 2013, 37(4): 496-505.
|
12. |
Park H, Choi KH, Choi SB, et al. Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea. Yonsei Med J, 2011, 52(5): 753-760.
|
13. |
储开建, 陆崇德, 姚晓平. 肝细胞-胆管细胞混合型肝癌的诊治进展. 中华肝胆外科杂志, 2012, (7): 561-563.
|
14. |
Lee SD, Park SJ, Han SS, et al. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Hepatobiliary Pancreat Dis Int, 2014, 13(6): 594-601.
|
15. |
O’Connor K, Walsh JC, Schaeffer DF. Combined hepatocellular-cholangiocarcinoma (cHCC-CC): a distinct entity. Ann Hepatol, 2014, 13(3): 317-322.
|
16. |
Connell LC, Harding JJ, Shia J, et al. Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Chin Clin Oncol, 2016, 5(5): 66.
|
17. |
Panjala C, Senecal DL, Bridges MD, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant, 2010, 10(5): 1263-1267.
|
18. |
Lee CH, Hsieh SY, Chang CJ, et al. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. J Gastroenterol Hepatol, 2013, 28(1): 122-127.
|
19. |
Zhan Q, Shen BY, Deng XX, et al. Clinical and pathological analysis of 27 patients with combined hepatocellular-cholangiocarcinoma in an Asian center. J Hepatobiliary Pancreat Sci, 2012, 19(4): 361-369.
|
20. |
张捷, 熊先泽, 程南生. 31 例混合型肝癌的临床病理特点与预后因素分析. 中国普外基础与临床杂志, 2014, 21(4): 432-436.
|
21. |
Lee JH, Chung GE, Yu SJ, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol, 2011, 45(1): 69-75.
|
22. |
Ijichi H, Shirabe K, Taketomi A, et al. Clinical usefulness of (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for patients with primary liver cancer with special reference to rare histological types, hepatocellular carcinoma with sarcomatous change and combined hepatocellular and cholangiocarcinoma. Hepatol Res, 2013, 43(5): 481-487.
|
23. |
Fowler KJ, Sheybani A, Parker RA 3rd, et al. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol, 2013, 201(2): 332-339.
|
24. |
Ariizumi S, Kotera Y, Katagiri S, et al. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor. Ann Surg Oncol, 2012, 19(5): 1628-1636.
|
25. |
Magistri P, Tarantino G, Serra V, et al. Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes. Dig Liver Dis, 2017, 49(5): 467-470.
|